BioSpace News Archive

Kraig Biocraft Laboratories, Inc. announces today that it has begun the scale up of its recently announced second generation Dragon Silk.

MiMedx Group, Inc. today announced that its Board of Directors has unanimously authorized the adoption of a limited duration shareholder rights plan (the “Rights Plan”) following receipt of notification from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that Nasdaq will suspend trading in the Company’s stock effective at the open of business on Thursday, November 8, 2018.

Shionogi & Co., Ltd. (hereafter “Shionogi”) announced it will present four posters on Mulpleta® (lusutrombopag), a once-daily, orally administered, small molecule thrombopoietin (TPO) receptor agonist, at The Liver Meeting®, the premiere annual meeting in the science and practice of hepatology from the American Association for the Study of Liver Diseases (AASLD) to be held in San Francisco, November 9-13, 2018.

Starch Medical a privately held manufacturer and marketer of polysaccharide based hemostatic products for use in controlling bleeding in surgery and trauma applications has announced the issuance of European Patent Number 2203053 for MODIFIED STARCH MATERIAL OF BIOCOMPATIBLE HEMOSTASIS.

Validation study confirms Dreampad induces feelings of relaxation and enhances sleep

Exact Imaging announced that compelling results derived from the ExactVu micro-ultrasound systemare featured in an unprecedented eight Clinical Posters, three Clinical Presentations and in two Hands-On Training Sessions at EAU’s 7th Meeting of the EAU Section of Urological Imaging (ESUI).

INSULIN-DEPENDENT PATIENTS MAY HAVE WORSE VASCULAR SURGICAL OUTCOMES

PEDD overpowers intratumoral high pressure, significantly increasing CAR-T into solid tumors

Third Quarter 2018 Highlights

Biostage, Inc. today announced appointing Ms. Ting Li to its Board of Directors after her valuable role this year in securing funding for the Company, effective November 6, 2018.